138 related articles for article (PubMed ID: 8548860)
1. Inhibition of the conversion of pre-interleukins-1 alpha and 1 beta to mature cytokines by p-benzoquinone, a metabolite of benzene.
Niculescu R; Bradford HN; Colman RW; Kalf GF
Chem Biol Interact; 1995 Dec; 98(3):211-22. PubMed ID: 8548860
[TBL] [Abstract][Full Text] [Related]
2. p-Benzoquinone, a reactive metabolite of benzene, prevents the processing of pre-interleukins-1 alpha and -1 beta to active cytokines by inhibition of the processing enzymes, calpain, and interleukin-1 beta converting enzyme.
Kalf GF; Renz JF; Niculescu R
Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1251-6. PubMed ID: 9118901
[TBL] [Abstract][Full Text] [Related]
3. Role for interleukin-1 (IL-1) in benzene-induced hematotoxicity: inhibition of conversion of pre-IL-1 alpha to mature cytokine in murine macrophages by hydroquinone and prevention of benzene-induced hematotoxicity in mice by IL-1 alpha.
Renz JF; Kalf GF
Blood; 1991 Aug; 78(4):938-44. PubMed ID: 1868253
[TBL] [Abstract][Full Text] [Related]
4. Decreased content of the IL1 alpha processing enzyme calpain in murine bone marrow-derived macrophages after treatment with the benzene metabolite hydroquinone.
Miller AC; Schattenberg DG; Malkinson AM; Ross D
Toxicol Lett; 1994 Nov; 74(2):177-84. PubMed ID: 7940599
[TBL] [Abstract][Full Text] [Related]
5. Hydroquinone, a bioreactive metabolite of benzene, inhibits apoptosis in myeloblasts.
Hazel BA; Baum C; Kalf GF
Stem Cells; 1996 Nov; 14(6):730-42. PubMed ID: 8948030
[TBL] [Abstract][Full Text] [Related]
6. Macrophage regulation of myelopoiesis is altered by exposure to the benzene metabolite hydroquinone.
Thomas DJ; Reasor MJ; Wierda D
Toxicol Appl Pharmacol; 1989 Mar; 97(3):440-53. PubMed ID: 2609342
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of RNA synthesis and interleukin-2 production in lymphocytes in vitro by benzene and its metabolites, hydroquinone and p-benzoquinone.
Post GB; Snyder R; Kalf GF
Toxicol Lett; 1985 Dec; 29(2-3):161-7. PubMed ID: 2418539
[TBL] [Abstract][Full Text] [Related]
8. Differential sensitivity of interleukin-1 alpha and -beta precursor proteins to cleavage by calpain, a calcium-dependent protease.
Kavita U; Mizel SB
J Biol Chem; 1995 Nov; 270(46):27758-65. PubMed ID: 7499244
[TBL] [Abstract][Full Text] [Related]
9. Involvement of a calpain-like protease in the processing of the murine interleukin 1 alpha precursor.
Carruth LM; Demczuk S; Mizel SB
J Biol Chem; 1991 Jul; 266(19):12162-7. PubMed ID: 2061304
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow stromal cell bioactivation and detoxification of the benzene metabolite hydroquinone: comparison of macrophages and fibroblastoid cells.
Thomas DJ; Sadler A; Subrahmanyam VV; Siegel D; Reasor MJ; Wierda D; Ross D
Mol Pharmacol; 1990 Feb; 37(2):255-62. PubMed ID: 2154673
[TBL] [Abstract][Full Text] [Related]
11. Benzene-induced bone marrow cell depression caused by inhibition of the conversion of pre-interleukins-1alpha and -1beta to active cytokines by hydroquinone, a biological reactive metabolite of benzene.
Niculescu R; Renz JF; Kalf GF
Adv Exp Med Biol; 1996; 387():329-37. PubMed ID: 8794226
[No Abstract] [Full Text] [Related]
12. Inhibition of human DNA topoisomerase II by hydroquinone and p-benzoquinone, reactive metabolites of benzene.
Hutt AM; Kalf GF
Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1265-9. PubMed ID: 9118903
[TBL] [Abstract][Full Text] [Related]
13. Metabolic activation of hydroquinone by macrophage peroxidase.
Schlosser MJ; Kalf GF
Chem Biol Interact; 1989; 72(1-2):191-207. PubMed ID: 2555072
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin H synthase catalyzed oxidation of hydroquinone to a sulfhydryl-binding and DNA-damaging metabolite.
Schlosser MJ; Shurina RD; Kalf GF
Chem Res Toxicol; 1990; 3(4):333-9. PubMed ID: 2133081
[TBL] [Abstract][Full Text] [Related]
15. Differences in xenobiotic detoxifying activities between bone marrow stromal cells from mice and rats: implications for benzene-induced hematotoxicity.
Zhu H; Li Y; Trush MA
J Toxicol Environ Health; 1995 Oct; 46(2):183-201. PubMed ID: 7563217
[TBL] [Abstract][Full Text] [Related]
16. Suppression of bone marrow stromal cell function by benzene and hydroquinone is ameliorated by indomethacin.
Gaido KW; Wierda D
Toxicol Appl Pharmacol; 1987 Jul; 89(3):378-90. PubMed ID: 3111015
[TBL] [Abstract][Full Text] [Related]
17. Erythroid progenitor cells that survive benzene exposure exhibit greater resistance to the toxic benzene metabolites benzoquinone and hydroquinone.
Neun DJ; Penn A; Snyder CA
Arch Toxicol; 1994; 68(9):535-40. PubMed ID: 7998818
[TBL] [Abstract][Full Text] [Related]
18. In vitro effects of benzene metabolites on mouse bone marrow stromal cells.
Gaido K; Wierda D
Toxicol Appl Pharmacol; 1984 Oct; 76(1):45-55. PubMed ID: 6484990
[TBL] [Abstract][Full Text] [Related]
19. Prevention of benzene-induced myelotoxicity and prostaglandin synthesis in bone marrow of mice by inhibitors of prostaglandin H synthase.
Pirozzi SJ; Schlosser MJ; Kalf GF
Immunopharmacology; 1989; 18(1):39-55. PubMed ID: 2504682
[TBL] [Abstract][Full Text] [Related]
20. An interaction of benzene metabolites reproduces the myelotoxicity observed with benzene exposure.
Eastmond DA; Smith MT; Irons RD
Toxicol Appl Pharmacol; 1987 Oct; 91(1):85-95. PubMed ID: 2823417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
